These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 9. Clinical study of urinary NAG activity in patients with various kidney diseases]. Suzuki M; Asano Y Rinsho Byori; 1983 Sep; Spec No 56():139-46. PubMed ID: 6663755 [No Abstract] [Full Text] [Related]
5. [Kidney involvement in industrial exposure to lead and cadmium]. Balkarov IM; Dupliankin SA; Eliseeva NA; Kondakhchan MA; Barashkov GK; Lebedeva MV; Kriachnevskaia LN Ter Arkh; 1995; 67(5):34-6. PubMed ID: 7638774 [No Abstract] [Full Text] [Related]
6. Metallothionein 1A polymorphisms may influence urine uric acid and N-acetyl-beta-D-glucosaminidase (NAG) excretion in chronic lead-exposed workers. Yang CC; Chen HI; Chiu YW; Tsai CH; Chuang HY Toxicology; 2013 Apr; 306():68-73. PubMed ID: 23429061 [TBL] [Abstract][Full Text] [Related]
7. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 8. Preclinical evaluation of the urinary NAG activities and their fluctuations in kidney diseases]. Ishida M; Fujino N; Maeba T; Sugiyama M; Kanazawa T; Owada S; Inoue T; Ozawa S; Amakawa T Rinsho Byori; 1983 Sep; Spec No 56():132-8. PubMed ID: 6663754 [No Abstract] [Full Text] [Related]
8. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 6. Preclinical evaluation of the urinary NAG activity and its relation to kidney function tests]. Sano K; Uno E Rinsho Byori; 1983 Sep; Spec No 56():111-21. PubMed ID: 6663752 [No Abstract] [Full Text] [Related]
9. [Urinary enzymes: early biochemical indicators in the biological monitoring study of subjects exposed to styrene]. Malaguti Aliberti L; Severini GC Minerva Med; 1989 Apr; 80(4):383-8. PubMed ID: 2566961 [TBL] [Abstract][Full Text] [Related]
10. Elevation of urinary N-acetyl-beta-D-glucosaminidase and beta-galactosidase activities in workers with long-term exposure to aromatic nitro-amino compounds. Yoshida M; Sunaga M; Hara I; Katsumata M; Minami M Bull Environ Contam Toxicol; 1989 Jul; 43(1):1-8. PubMed ID: 2758123 [No Abstract] [Full Text] [Related]
11. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 11. Clinical significance of urinary NAG activity in patients with kidney diseases and those with kidney homografts]. Ishida Y; Kawada T; Sugino N Rinsho Byori; 1983 Sep; Spec No 56():160-7. PubMed ID: 6363758 [No Abstract] [Full Text] [Related]
12. [Detection of early kidney damage in workers exposed to lead, mercury, and cadmium (author's transl)]. Schaller KH; Gonzales J; Thürauf J; Schiele R Zentralbl Bakteriol Mikrobiol Hyg B; 1980 Sep; 171(4-5):320-35. PubMed ID: 6161498 [TBL] [Abstract][Full Text] [Related]
13. [Significance of urinary N-acetyl-beta-D-glucosaminidase analysis in clinical tests]. Sugita O; Yakata M Nihon Rinsho; 1989 Dec; 48 Suppl():363-5. PubMed ID: 2621903 [No Abstract] [Full Text] [Related]
14. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 4. Preclinical evaluation of the urinary NAG activity and changes in renal diseases]. Yakata M; Sugita O; Sakai T; Uchiyama K; Wada K Rinsho Byori; 1983 Sep; Spec No 56():90-101. PubMed ID: 6663765 [No Abstract] [Full Text] [Related]
15. [Renal tolerance of aztreonam evaluated on the basis of the urinary excretion of N-acetyl-beta-glucosaminidase]. Albertazzi A; Cappelli P; Di Paolo B; Evangelista M G Ital Chemioter; 1985; 32(2):419-21. PubMed ID: 3833581 [No Abstract] [Full Text] [Related]
16. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from he kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 5. Preclinical evaluation of the urinary NAG activity and its fluctuations in kidney and liver diseases and diabetes mellitus]. Kin K; Akiyoshi R; Ohashi M; Nihonyanagi Y Rinsho Byori; 1983 Sep; Spec No 56():102-10. PubMed ID: 6663751 [No Abstract] [Full Text] [Related]
17. [Urinary N-acetyl-beta-glucosaminidase as index of renal toxicity (author's transl)]. Oudart N; Marcher K; Lacour B; Boulu RG; Guichard C Toxicol Eur Res; 1981 May; 3(3):149-51. PubMed ID: 7281165 [TBL] [Abstract][Full Text] [Related]
18. [Comparison of urinary N-acetyl-beta-D-glucosaminidase activity determined by using 24-hour and 2-hour urine]. Uno E; Sano-Shiba K; Ida T; Sakurai S Rinsho Byori; 1986 May; 34(5):590-4. PubMed ID: 3761626 [No Abstract] [Full Text] [Related]
19. [N-acetyl-beta-D-glucosaminidase: a sensible enzyme to functional and morphologic renal changes]. Kopf SR; Nahmod VE Medicina (B Aires); 1988; 48(2):215-6. PubMed ID: 3231086 [No Abstract] [Full Text] [Related]
20. The predictive value of urinary N-acetyl-beta-D-glucosaminidase in evaluating aminoglycoside nephrotoxicity. Guh JY; Su YH; Chen HJ; Tsai JH Taiwan Yi Xue Hui Za Zhi; 1985 Oct; 84(10):1099-107. PubMed ID: 3866825 [No Abstract] [Full Text] [Related] [Next] [New Search]